Literature DB >> 23057670

Avidin functionalized maghemite nanoparticles and their application for recombinant human biotinyl-SERCA purification.

Massimiliano Magro1, Adele Faralli, Davide Baratella, Ilenia Bertipaglia, Sara Giannetti, Gabriella Salviulo, Radek Zboril, Fabio Vianello.   

Abstract

We report on the surface characterization, functionalization, and application of stable water suspensions of novel surface active maghemite nanoparticles (SAMNs), characterized by a diameter of 11 ± 2 nm and possessing peculiar colloidal properties and surface interactions. These features permitted the acquisition of titration curves and aqueous UV-vis spectra and suggested a role played by surface under-coordinated iron atoms. This new class of nanoparticles was obtained through an easy, inexpensive, one-step, green procedure and functionalized with ligands of high biotechnological interest, such as biotin and avidin, by simple incubation in aqueous solution. Bound avidin was determined by measuring the disappearance of free avidin absorbance at 280 nm, as a function of increasing nanoparticle concentration, showing the presence of 10 ± 3 avidin molecules per nanoparticle. The biological activity of the SAMN@avidin complex was evaluated and the number of available biotin binding sites was determined, using biotinyl-fluorescein as a probe, showing that each bound avidin molecule is able to bind 2.8 ± 0.8 biotin molecules, confirming the maintenance of biological activity and excellent binding capacity of the SAMN@avidin complex. Furthermore a Langmuir isotherm model was used to describe the biomolecule specific monolayer adsorption onto the particle surface, and in the case of avidin, the maximum adsorption capacity was 100 ± 27 μg avidin/mg SAMN, whereas the binding constant is 45.18 μL μg(-1). The SAMN@avidin complex was characterized by UV-vis spectroscopy, quartz crystal microbalance, FTIR spectroscopy, and transmission electron microscopy. Finally, SAMN@avidin was applied for the large scale purification of recombinant biotinylated human sarco/endoplasmic reticulum Ca(2+)-ATPase (hSERCA-2a), expressed by Saccharomyces cerevisiae. The protein was magnetically purified, and about 500 μg of a 70% pure hSERCA-2a were recovered from 4 L of yeast culture, with a purification yield of 64%.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23057670     DOI: 10.1021/la303148u

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  8 in total

Review 1.  Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications.

Authors:  Wei Wu; Zhaohui Wu; Taekyung Yu; Changzhong Jiang; Woo-Sik Kim
Journal:  Sci Technol Adv Mater       Date:  2015-04-28       Impact factor: 8.090

2.  Molecular Recognition of Proteins through Quantitative Force Maps at Single Molecule Level.

Authors:  Carlos Marcuello; Rocío de Miguel; Anabel Lostao
Journal:  Biomolecules       Date:  2022-04-18

3.  Colorimetric Kit for Rapid Porcine Circovirus 2 (PCV-2) Diagnosis.

Authors:  Caroline Rodrigues Basso; Ana Carolina Yamakawa; Taís Fukuta Cruz; Valber Albuquerque Pedrosa; Massimiliano Magro; Fabio Vianello; João Pessoa Araújo Júnior
Journal:  Pathogens       Date:  2022-05-12

4.  Optimisation of recombinant production of active human cardiac SERCA2a ATPase.

Authors:  Ana V Antaloae; Cédric Montigny; Marc le Maire; Kimberly A Watson; Thomas L-M Sørensen
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

5.  The surface reactivity of iron oxide nanoparticles as a potential hazard for aquatic environments: A study on Daphnia magna adults and embryos.

Authors:  Massimiliano Magro; Marco De Liguoro; Eleonora Franzago; Davide Baratella; Fabio Vianello
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

6.  Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist--an initial in vitro study.

Authors:  Josef Skopalik; Katerina Polakova; Marketa Havrdova; Ivan Justan; Massimiliano Magro; David Milde; Lucia Knopfova; Jan Smarda; Helena Polakova; Eva Gabrielova; Fabio Vianello; Jaroslav Michalek; Radek Zboril
Journal:  Int J Nanomedicine       Date:  2014-11-20

7.  Enzyme Immobilization on Maghemite Nanoparticles with Improved Catalytic Activity: An Electrochemical Study for Xanthine.

Authors:  Massimiliano Magro; Davide Baratella; Andrea Venerando; Giulia Nalotto; Caroline R Basso; Simone Molinari; Gabriella Salviulo; Juri Ugolotti; Valber A Pedrosa; Fabio Vianello
Journal:  Materials (Basel)       Date:  2020-04-10       Impact factor: 3.623

Review 8.  Nanotechnology-Based Strategies to Develop New Anticancer Therapies.

Authors:  Massimiliano Magro; Andrea Venerando; Alberto Macone; Gianluca Canettieri; Enzo Agostinelli; Fabio Vianello
Journal:  Biomolecules       Date:  2020-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.